Rafael Fernández-Chacón

Rafael Fernández-Chacón

Auto-generated profile, based on publicly available information

Rafael Fernández-Chacón

Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2001 in Nature
Verified
Journal Article
Closed access
PDF file
RFRafael Fernández-Chacón
Rafael Fernández-Chacón
AKAndreas Königstorfer
Andreas Königstorfer
SGStefan H. Gerber
Stefan H. Gerber
JGJesús García
Jesús García
MMMaria F. Matos
Maria F. Matos
TSThomas C. Südhof
Thomas C. Südhof

1 November 2005 in Cell
Verified
Journal Article
Closed access
SCSreeganga Chandra
Sreeganga Chandra
GGGilbert Gallardo
Gilbert Gallardo
RFRafael Fernández-Chacón
Rafael Fernández-Chacón
OSOliver M. Schlüter
Oliver M. Schlüter
TSThomas C. Südhof
Thomas C. Südhof

1 June 1993 in Nature
Verified
Journal Article
Closed access
GTG. Alvarez de Toledo
G. Alvarez de Toledo
RFR. Fernández-Chacón
R. Fernández-Chacón
JFJ. M. Fernández
J. M. Fernández
RFR. Fern
R. Fern

1 April 2004 in Neuron
Verified
Journal Article
Closed access
RFRafael Fernández-Chacón
Rafael Fernández-Chacón
MWMarkus Wölfel
Markus Wölfel
HNHiroshi Nishimune
Hiroshi Nishimune
LTLucia Tabares
Lucia Tabares
FSFrank Schmitz
Frank Schmitz
TSThomas C Südhof
Thomas C Südhof

1 May 2001 in Neuron
Verified
Journal Article
Closed access
SSShuzo Sugita
Shuzo Sugita
WHWeiping Han
Weiping Han
SBStefan Butz
Stefan Butz
XLXinran Liu
Xinran Liu
RFRafael Fernández-Chacón
Rafael Fernández-Chacón
TSThomas C. Südhof
Thomas C. Südhof

13 February 2007 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
DADeniz Atasoy
Deniz Atasoy
SSSusanne Schoch
Susanne Schoch
AHAngela Ho
Angela Ho
KNKrisztina A. Nadasy
Krisztina A. Nadasy
XLXinran Liu
Xinran Liu
TSThomas C. Südhof
Thomas C. Südhof
CASK is an evolutionarily conserved multidomain protein composed of an N-terminal Ca 2+ /calmodulin-kinase domain, central PDZ and SH3 domains, and a C-terminal guanylate kinase domain. Many potential activities for CASK have been suggested, including functions in scaffolding the synapse, in organizing ion channels, and in regulating neuronal gene transcription. To better define the physiological importance of CASK, we have now analyzed CASK “knockdown” mice in which CASK expression was suppressed by ≈70%, and CASK knockout (KO) mice, in which CASK expression was abolished. CASK knockdown mice are viable but smaller than WT mice, whereas CASK KO mice die at first day after birth. CASK KO mice exhibit no major developmental abnormalities apart from a partially penetrant cleft palate syndrome. In CASK-deficient neurons, the levels of the CASK-interacting proteins Mints, Veli/Mals, and neurexins are decreased, whereas the level of neuroligin 1 (which binds to neurexins that in turn bind to CASK) is increased. Neurons lacking CASK display overall normal electrical properties and form ultrastructurally normal synapses. However, glutamatergic spontaneous synaptic release events are increased, and GABAergic synaptic release events are decreased in CASK-deficient neurons. In contrast to spontaneous neurotransmitter release, evoked release exhibited no major changes. Our data suggest that CASK, the only member of the membrane-associated guanylate kinase protein family that contains a Ca 2+ /calmodulin-dependent kinase domain, is required for mouse survival and performs a selectively essential function without being in itself required for core activities of neurons, such as membrane excitability, Ca 2+ -triggered presynaptic release, or postsynaptic receptor functions.